Short-acting agents slow down the stomach more than long-acting ones, though both types affect how we digest food
Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration
These injections slow gastric emptying and increase feelings of fullness, potentially leading to weight loss
The first GLP-1 drugs developed are self-administered via daily or weekly subcutaneous (under the skin) injections using a pre-filled pen
This mechanism is particularly important because insulin release occurs only when blood glucose levels are elevated, which significantly reduces the risk of hypoglycemia compared to insulin secretagogues like sulfonylureas
Quaas AM, Kono N, Mack WJ, Hodis HN, Felix JC, Paulson RJ, et al